SCYNEXIS, Inc. to Present at the 29th Annual ROTH Conference
March 07 2017 - 8:05AM
Drug development company SCYNEXIS, Inc. (NASDAQ:SCYX) today
announced that the Company will present at the 29th Annual ROTH
Conference at the Ritz Carlton Laguna Niguel in Dana Point on
Tuesday, March 14, 2017 at 5:30 p.m. PT.
A live webcast will be available on the Investors section of the
Company's website: www.scynexis.com. A replay of the presentation
will be available approximately two hours after the event and will
be available for two weeks following the presentation.
About SCYNEXISSCYNEXIS is a drug development
company committed to the development and commercialization of novel
anti-infectives to address significant unmet therapeutic needs. We
are developing our lead product candidate, SCY-078, as an oral and
IV drug for the treatment of several fungal infections, including
serious and life-threatening invasive fungal infections. For more
information, visit www.scynexis.com.
CONTACT:
Media Relations
Cammy Duong
MacDougall Biomedical Communications
Tel: 781.591.3443
cduong@macbiocom.com
Investor Relations
Susan Kim
Argot Partners
Tel: 212-203-4433
susan@argotpartners.com
Scynexis (NASDAQ:SCYX)
Historical Stock Chart
From Apr 2024 to May 2024
Scynexis (NASDAQ:SCYX)
Historical Stock Chart
From May 2023 to May 2024